Apotex warned by U.S. to raise quality control standards
Canadian generic drug maker Apotex Inc.'s exports to the United States could be blocked if the company doesn't correct quality control problems, according to a warning letter from a U.S. regulator.
The U.S. Food and Drug Administration's website includes a warning letter sent to Apotex describing "repeated deficiencies" in quality control, such as ensuring drug products at one of its Toronto-area plant were free of bacterial or fungal contamination.
- Read More... about Apotex warned by U.S. to raise quality control standards
- Log in or register to post comments



